USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Top 10 Strategic Imperatives in the Life Sciences Industry, 2025
Key Challenges, Trends, and Changes Transforming the Life Sciences Industry
19-Feb-2025
Global
Market Research
PFTF-01-00-00-00
HC_2025_1314
Owing to constant developments and challenges in the life sciences industry, stakeholders must continue to be adaptable, innovative, and competitive to thrive. Industry leaders must reconsider their strategic positions annually by understanding the main forces behind the transformation, including potential, challenges, and drivers.
This analysis explores the strategic imperatives shaping and transforming the life sciences industry. They are as follows:
SaaS evolution provides adaptive intelligence for laboratories
CDMOs augment competencies in new modalities, and digital transformation delivers end-to-end partnerships
Expanding direct-to-consumer (DTC) genetic testing beyond ancestry testing to multi-pathogenic STIs
Uncertainty about trade wars disrupts pharmaceutical supply chains
Decentralized clinical trials (DCTs) boost efficiency for CGTs and rare disorders
Next-generation sequencing (NGS) and liquid biopsy revolutionize oncology diagnostics
Failed clinical trials and shifting market conditions setback biotech innovation
ESG initiatives climb to the top of CEOs' strategic priorities
Real-world insight (RWI) emerges as a strategic compass point to reimagine commercial strategies
CRISPR technology advances biologics R&D
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
Top Transformations Impacting the Growth of the Life Sciences Industry
Key Industry Trends and Challenges
Transformation 1: SaaS Evolution Provides Adaptive Intelligence for Laboratories
Transformation 1: SaaS Evolution Provides Adaptive Intelligence for Laboratories (continued)
Transformation 2: CDMOs Augment Competencies in New Modalities, and Digital Transformation Delivers End-to-End Partnerships
Transformation 2: CDMOs Augment Competencies in New Modalities, and Digital Transformation Delivers End-to-End Partnerships (continued)
Transformation 3: Expanding Direct-to-Consumer (DTC) Genetic Testing Beyond Ancestry Testing to Multi-pathogenic STIs
Transformation 3: Expanding DTC Genetic Testing Beyond Ancestry Testing to Multi-pathogenic STIs (continued)
Transformation 4: Uncertainty About Trade Wars Disrupts Pharmaceutical Supply Chains
Transformation 4: Uncertainty About Trade Wars Disrupts Pharmaceutical Supply Chains (continued)
Transformation 5: Decentralized Clinical Trials (DCTs) Boosting Efficiency for CGTs and Rare Disorders
Transformation 5: DCTs Boosting Efficiency for CGTs and Rare Disorders (continued)
Transformation 6: Next-generation Sequencing (NGS) and Liquid Biopsy Revolutionize Oncology Diagnostics
Transformation 6: NGS and Liquid Biopsy Revolutionize Oncology Diagnostics (continued)
Transformation 7: Failed Clinical Trials and Shifting Market Conditions Setback Biotech Innovation
Transformation 7: Failed Clinical Trials and Shifting Market Conditions Setback Biotech Innovation (continued)
Transformation 8: ESG Initiatives Climb to the Top of CEOs' Strategic Priorities
Transformation 8: ESG Initiatives Climb to the Top of CEOs' Strategic Priorities (continued)
Transformation 9: Real-world Insight (RWI) Emerges as a Strategic Compass Point to Reimagine Commercial Strategies
Transformation 9: RWI Emerges as a Strategic Compass Point to Reimagine Commercial Strategies (continued)
Transformation 10: CRISPR Technology Advances Biologics R&D
Transformation 10: CRISPR Technology Advances Biologics R&D (continued)
Frost & Sullivan Analytics Perspectives
Benefits and Impacts of Growth Opportunities
Next Steps
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Pharmaceuticals research
16 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Precision Therapeutics, AI-Enabled Discovery and Bioengineering, Regenerative Medicine, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming precision therapeutics, regenerative medicine, AI-enabled discovery, laboratory automation, targeted delivery, vaccines, and biomanufactu...
15 Oct 2026 | Global | Frost Radar
Frost Radar™: US and European Mammalian Contract Development and Manufacturing Organizations, 2026
The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As mo...
23 Sep 2026 | Global | Technology Research
Programmable Epigenome Editing for Disease Reversal
Programmable epigenome editing is developing as a distinct approach to controlling gene activity without changing the underlying DNA sequence. This report examines the landscape from the core editing technologies and delivery systems through the companies, academic programs and therapeutic applicati...
18 Sep 2026 | Global | Technology Research
Innovations and Growth Opportunities in AI-Enabled Discovery and Diagnostics, Precision Therapeutics, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming AI-enabled discovery, precision diagnostics, cell engineering, targeted therapeutics, vaccines, and skin health across oncology, metaboli...
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.